The U.S. government has handed Moderna almost $600 million to accelerate its work on various bird flu vaccines as well as work on mRNA vaccines for other influenza strains with pandemic potential.

A bad seven-month stretch just got worse for Moderna (NASDAQ: MRNA). The messenger RNA (mRNA) pioneer provided a business and pipeline update at the J.P. Morgan Healthcare Conference on Monday.

Moderna (NASDAQ: MRNA) was one of the hottest companies of early pandemic times, delivering a coronavirus vaccine to market in record time and quickly generating blockbuster revenue from it.

There have been 67 confirmed human bird flu cases in the U.S. since April 2024. Moderna has been awarded approximately $590 million from the federal government to help speed up the development of ...

Poised, powerful, and intentional, Justice Jackson sent a message with her main accessory of choice: a bold, layered cowrie shell necklace paired with matching earrings. Against her black ...

Read more: LA fires: Why fast-moving wildfires and those started by human activities are more destructive and harder to contain Nights are warming faster than days globally, and dusk has brought ...

Moderna (NASDAQ:MRNA) was among the notable gainers on Wednesday after Oracle (NYSE:ORCL) Chairman Larry Ellison highlighted the AI's potential in the development of messenger RNA-based cancer ...

Jan 17 (Reuters) - The U.S. government has awarded Moderna (MRNA.O), opens new tab $590 million to advance the development of its bird flu vaccine, as the country doubles down on efforts to tackle ...

The DJI Mic Mini is the ideal first microphone upgrade for new content creators who want to boost the quality of their audio. It's also a fine choice for more experienced creators who need a tiny ...

Comprised of cowrie shells, the collar was elegant and a unique take on garbs worn during monumental, history-defining moments. US Supreme Court Chief Justice John Roberts, US Supreme Court ...

In 2023, Moderna initiated a study on a “pandemic influenza vaccine” to protect against H5 and H7 avian influenza viruses. In July, the company received $176 million from HHS toward its ...

Moderna stock has been under pressure amid declining sales of its COVID-19 vaccine. The company projects optimism in its long-term outlook, believing that several pending product approvals can ...